Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Jun 26, 2024
| Ashley Henyan
Blog: Bill Addressing Drug Shortages Provides Long Overdue Relief from Penalties Hurting Generic Drug Market
Blog
Jun 25, 2024
| AAM
Senate Finance Committee Bill Addressing Drug Shortages Would Provide Long Overdue Relief from Penalties Hurting Generic Drug Market
Video
Jun 20, 2024
| Ericka Nguyen
Join Us at Access! 2025 in Amelia Island, Florida
Press Release
May 30, 2024
| Brian Hart
AAM Submits Comments to HHS and FTC on the Impact of GPOs and Wholesalers on Access to Generic Medicines
Press Release
May 21, 2024
| Brian Hart
AAM Applauds Senate Judiciary Committee Efforts to Protect Patients and Skinny Labeling
Press Release
Apr 17, 2024
| Brian Hart
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?
Video
Apr 16, 2024
| Aquera Agee
Exploring the Future of Generics and Biosimilars at GRx+Biosims 2024
Blog
Apr 16, 2024
| Michael Sargent
Seniors Pay More for Generic Medicines Every Year While Prices Continue to Fall. Why?
Blog
Feb 22, 2024
| Jennifer Soup
Access! 2024 - Charting a Sustainable Path for Generics and Biosimilars
Press Release
Feb 20, 2024
| Brian Hart
Medicare Plans Increase Patient Costs for Generic Medicines
Press Release
Feb 14, 2024
| Brian Hart
AAM Commends HHS and FTC Call for Information and Solutions on Drug Shortages and Patient Access to Generics and Biosimilars
Press Release
Feb 5, 2024
| Brian Hart
AAM White Paper: Hatch-Waxman Turns 40
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action